Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EXACT Sciences
EXACT Sciences
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Motley Fool
Wed, 03/4/20 - 12:05 am
EXACT Sciences
M&A
diagnostics
cancer
Paradigm Diagnostics
Viomics
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Thu, 12/19/19 - 12:05 am
Pfizer
colorectal cancer
EXACT Sciences
FDA
Braftovi
Cologuard
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Yahoo/Zacks.com
Wed, 09/25/19 - 09:10 am
EXACT Sciences
Cologuard
diagnostics
colorectal cancer
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
Mon, 07/29/19 - 11:21 pm
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal
Xconomy
Mon, 07/29/19 - 09:28 am
EXACT Sciences
M&A
Genomic Health
diagostics
How Exact Sciences Reinvented Itself
Medical Devices and Diagnostics Industry
Mon, 05/27/19 - 11:48 pm
diagnostics
EXACT Sciences
Kevin Conroy
Why Exact Sciences Stock Sank Today
Motley Fool
Wed, 03/27/19 - 11:31 pm
EXACT Sciences
Affordable Care Act
Cologuard
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround
Xconomy
Wed, 03/20/19 - 08:18 pm
EXACT Sciences
Kevin Conroy
diagnostics
colorectal cancer
Cologuard
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Yahoo/Motley Fool
Sun, 02/24/19 - 11:22 pm
EXACT Sciences
earnings
Cologuard
4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test
Motley Fool
Tue, 01/29/19 - 12:01 pm
23andMe
EXACT Sciences
diagnostics
colorectal cancer
Cologuard
Behind the Exact Sciences/Pfizer Cologuard co-promotion deal
Medical Marketing and Media
Fri, 08/24/18 - 11:05 am
Pfizer
EXACT Sciences
Cologuard
diagnostics
colon cancer
Exact Sciences signs marketing deal with Pfizer for cancer test
Yahoo/Reuters
Wed, 08/22/18 - 10:02 am
Pfizer
EXACT Sciences
Cologuard
diagnostics
colon cancer
Exact Sciences Misses Revenue Estimates by $1.8 Million -- But It Cost the Company a Lot More
Motley Fool
Thu, 08/2/18 - 10:12 am
EXACT Sciences
earnings
Why Exact Sciences Shares Are Rallying 13.8% in 2018
Motley Fool
Sun, 07/8/18 - 11:08 am
EXACT Sciences
colon cancer
American Cancer Society
Cologuard
20 Million More Potential Customers for Cologuard
Motley Fool
Mon, 06/4/18 - 09:40 am
EXACT Sciences
colorectal cancer
Cologuard
diagnostics
Exact Sciences Needs New Study to Fully Benefit From ACS Change
Xconomy
Thu, 05/31/18 - 08:15 pm
EXACT Sciences
colorectal cancer
American Cancer Society
Cologuard
2 Reasons Exact Sciences Investors Shouldn't Worry -- and 1 Reason They Should
Motley Fool
Tue, 02/27/18 - 11:46 am
EXACT Sciences
earnings
Cologuard
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales
Xconomy
Mon, 02/26/18 - 10:29 am
EXACT Sciences
Cologuard
Flu
diagnostics
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »